Study tracking patients with hypophosphatasia over time
Part of Genetic & congenital, Hormones & metabolism clinical trials.
This study follows people who already have hypophosphatasia (HPP) to better understand how the condition changes over time. It may help doctors recognize patterns and improve care, even if you are not receiving a new treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your legal representative) must be able to give consent to join the study
- You must already have a confirmed diagnosis of hypophosphatasia (HPP)
- Your diagnosis must be supported by one or more test results (low ALP for your age, high PLP, X-ray bone changes, or an ALPL gene result)
- You must be a current patient in the Duke University health system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a long-term observational study (not a drug trial) that follows adults with signs of hypophosphatasia, a condition linked to very low alkaline phosphatase levels and sometimes a gene change. It aims to better understand the condition over time and how symptoms look and progress.
This study follows children with hypophosphatasia (HPP) to better understand how they do while receiving asfotase alfa. It may help improve care for families living with pediatric-onset HPP.
This study looks at how changes in the ALPL gene affect the natural course of hypophosphatasia (HPP). It aims to learn more about the condition in people who have not received enzyme replacement therapy.
This study aims to find better ways to diagnose hypophosphatasia (HPP) in adults who see a rheumatologist. If your doctor suspects HPP and you have a low ALP blood test, you may be able to help researchers develop a screening tool.
This trial is a registry that collects information about people with hypophosphatasia to help researchers understand the condition better. It may help future studies, but it’s not a treatment trial.
This study follows adults with hypoparathyroidism to better understand what symptoms and lab levels change over time. It may help doctors plan future treatments by learning the natural course of the condition, even if you already take standard medicines.
Hear when a new Hypophosphatasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.